These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9777861)

  • 21. Tamoxifen and the breast cancer prevention trial: women helping women.
    Healy BP
    J Womens Health; 1998 Apr; 7(3):279-80. PubMed ID: 9580905
    [No Abstract]   [Full Text] [Related]  

  • 22. Breast cancer trial stopped early.
    Josefson D
    BMJ; 1998 Apr; 316(7139):1187. PubMed ID: 9583923
    [No Abstract]   [Full Text] [Related]  

  • 23. Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer.
    Barakat RR
    J Clin Oncol; 1999 Jul; 17(7):1967-8. PubMed ID: 10561245
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of tamoxifen on the endometrium.
    Barakat RR
    Oncology (Williston Park); 1995 Feb; 9(2):129-34; discussion 139-40, 142. PubMed ID: 8771096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The breast cancer prevention trial: should women at risk take tamoxifen?
    McKeon VA
    J Obstet Gynecol Neonatal Nurs; 1999; 28(6 Suppl 1):34-8. PubMed ID: 10608495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Status of antiestrogen breast cancer prevention trials.
    Powles TJ
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):28-31. PubMed ID: 9556788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endometrial cancer and recurrence with hormonal manipulation.
    Ghosh P; Fawzi H
    J Obstet Gynaecol; 2004 Feb; 24(2):192-3. PubMed ID: 14766474
    [No Abstract]   [Full Text] [Related]  

  • 29. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
    Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
    Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tamoxifen and breast cancer: is everything known already?].
    Marchetti P; Porzio G; Trapasso T; Baldi PL; Ficorella C
    Tumori; 1998; 84(6):A1-5. PubMed ID: 10080686
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognosis of tamoxifen-associated endometrial cancer.
    Lasset C; Mignotte H; Bonadona V; Chauvin F
    J Clin Oncol; 1998 Jul; 16(7):2573. PubMed ID: 9667283
    [No Abstract]   [Full Text] [Related]  

  • 33. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
    McCaul KA
    Obstet Gynecol; 2005 Jan; 105(1):217-8; author reply 218-9. PubMed ID: 15625169
    [No Abstract]   [Full Text] [Related]  

  • 34. Adjuvant and extended adjuvant use of aromatase inhibitors: reducing the risk of recurrence and distant metastasis.
    Gligorov J; Pritchard K; Goss P
    Breast; 2007 Dec; 16 Suppl 3():S1-9. PubMed ID: 18061455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tamoxifen and the uterus and endometrium.
    Stewart HJ; Knight GM
    Lancet; 1989 Feb; 1(8634):375-6. PubMed ID: 18446929
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force.
    Nelson HD; Smith ME; Griffin JC; Fu R
    Ann Intern Med; 2013 Apr; 158(8):604-14. PubMed ID: 23588749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.
    Amir E; Seruga B; Niraula S; Carlsson L; Ocaña A
    J Natl Cancer Inst; 2011 Sep; 103(17):1299-309. PubMed ID: 21743022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients.
    Fisher B
    J Clin Oncol; 1996 Mar; 14(3):1027-39. PubMed ID: 8622007
    [No Abstract]   [Full Text] [Related]  

  • 39. Secretory endometrial adenocarcinoma in a tamoxifen user with breast cancer after menopause.
    Wu CJ; Peng YJ; Yu MH; Chen CH
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):88-90. PubMed ID: 17389201
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use.
    Kim SI; Lee Y; Son Y; Jun SY; Yun S; Bae HS; Lim MC; Jung SY; Joo J; Lee ES
    J Korean Med Sci; 2015 Nov; 30(11):1604-10. PubMed ID: 26539004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.